Stanton L. Gerson
Affiliations: | Case Western Reserve University School of Medicine, Cleveland, OH, United States |
Area:
Stem cells, DNA repairWebsite:
http://cancer.case.edu/about/leadership/stanton-l-gerson-md.htmlGoogle:
"Stanton Gerson"Children
Sign in to add trainee| Justin C. Roth | grad student | Case Western Medical School | |
| Steven P. Zielske | grad student | 2003 | Case Western |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Smith JN, Dawson DM, Christo KF, et al. (2021) 15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration. Jci Insight |
| Eads JR, Krishnamurthi SS, Saltzman J, et al. (2020) Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors. Investigational New Drugs |
| Smith JNP, Otegbeye F, Jogasuria AP, et al. (2020) Inhibition of 15-PGDH Protects Mice from Immune-mediated Bone Marrow Failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Ye R, Kundrapu S, Gerson SL, et al. (2019) Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma. Clinical Lymphoma, Myeloma & Leukemia |
| Srinivasan SS, Seenivasan R, Condie A, et al. (2019) Gold Nanoparticle-Based Fluorescent Theranostics for Real-Time Image-Guided Assessment of DNA Damage and Repair. International Journal of Molecular Sciences. 20 |
| Sloan AE, Roger L, Murphy C, et al. (2019) A phase I study of MGMT-P140K transfected hematopoetic progenitor cells (HPC) combined with TMZ/O6BG dose escalation for newly diagnosed, MGMT unmethylated glioblastoma: Tolerance and evidence of survival benefit. Journal of Clinical Oncology. 37: 2062-2062 |
| Hashemi Sadraei N, Feng Y, Du L, et al. (2018) High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. Lung Cancer (Amsterdam, Netherlands). 126: 48-54 |
| Desai A, Yan Y, Gerson SL. (2018) Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success. Stem Cells Translational Medicine |
| Patel R, Zhang L, Desai A, et al. (2018) Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure. Leukemia |
| Desai A, Yan Y, Gerson SL. (2018) Advances in therapeutic targeting of the DNA damage response in cancer. Dna Repair. 66: 24-29 |